Novo Holding Archives - 做厙勛圖 News /tag/novo-holding/ Data-driven reporting on private markets, startups, founders, and investors Mon, 16 Mar 2020 15:36:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.12 /wp-content/uploads/cb_news_favicon-150x150.png Novo Holding Archives - 做厙勛圖 News /tag/novo-holding/ 32 32 Chicago-Based Tempus Raises $100M At $5B Valuation For AI-Driven Healthcare /venture/chicago-based-tempus-raises-100m-at-5b-valuation-for-ai-driven-healthcare/ Mon, 16 Mar 2020 15:17:42 +0000 http://news.crunchbase.com/?p=26580 , a healthtech company started by 泭釵棗-款棗喝紳餃梗娶 , has a $100 million Series G round at a post-money valuation of $5 billion. The money comes less than 10 months after Tempus raised a $200 million at a pre-money valuation of $2.9 billion.

Subscribe to the 做厙勛圖 Daily

, , , and participated in the financing. With the latest round, Tempus has now raised $620 million since its September 2015 inception, according to 做厙勛圖 Previous backers include and Denmarks .

Tempus says it has built an operating system to deliver personalized cancer care. Its using its new capital to expand into other disease areas, including diabetes, depression and cardiology.

The startup is on a mission to redefine how genomic data is used in a clinical setting. Its built out an interactive analytical and machine-learning platform so patients can benefit from the treatment of others who came before.

Tempus genomics tests analyze DNA, RNA and proteomic data to understand a patients tumor at the molecular level with the goal of identifying customized treatment options.

Currently, Tempus works with thousands of oncologists across hundreds of medical systems. It claims to have the worlds largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful.

As anyone whos had a family member battle cancer can attest to, the thought of more personalized (and better!) care is more than welcome.

Illustration:

]]> /wp-content/uploads/2019/02/unidorn_doctor.png